Reference
Alston, C. L., Compton, A. G., Formosa, L. E., Strecker, V., Oláhová, M., Haack, T. B., . . . Taylor, R. W. (2016). Biallelic Mutations in TMEM126B Cause Severe Complex I Deficiency with a Variable Clinical Phenotype. Am J Hum Genet , 99 (1), 217-227. https://doi.org/10.1016/j.ajhg.2016.05.021
Beck, B. B., Baasner, A., Buescher, A., Habbig, S., Reintjes, N., Kemper, M. J., . . . Hoppe, B. (2013). Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies. Eur J Hum Genet , 21 (2), 162-172. https://doi.org/10.1038/ejhg.2012.139
Cartegni, L., Wang, J., Zhu, Z., Zhang, M. Q., & Krainer, A. R. (2003). ESEfinder: A web resource to identify exonic splicing enhancers.Nucleic Acids Res , 31 (13), 3568-3571. https://doi.org/10.1093/nar/gkg616
Darin, N., Oldfors, A., Moslemi, A. R., Holme, E., & Tulinius, M. (2001). The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities.Ann Neurol , 49 (3), 377-383.
Dunning, C. J., McKenzie, M., Sugiana, C., Lazarou, M., Silke, J., Connelly, A., . . . Ryan, M. T. (2007). Human CIA30 is involved in the early assembly of mitochondrial complex I and mutations in its gene cause disease. Embo j , 26 (13), 3227-3237. https://doi.org/10.1038/sj.emboj.7601748
Fassone, E., Taanman, J.-W., Hargreaves, I. P., Sebire, N. J., Cleary, M. A., Burch, M., & Rahman, S. (2011). Mutations in the mitochondrial complex I assembly factor NDUFAF1 cause fatal infantile hypertrophic cardiomyopathy. 48 (10), 691-697. https://doi.org/10.1136/jmedgenet-2011-100340 %J Journal of Medical Genetics
Fassone, E., Taanman, J. W., Hargreaves, I. P., Sebire, N. J., Cleary, M. A., Burch, M., & Rahman, S. (2011). Mutations in the mitochondrial complex I assembly factor NDUFAF1 cause fatal infantile hypertrophic cardiomyopathy. J Med Genet , 48 (10), 691-697. https://doi.org/10.1136/jmedgenet-2011-100340
Formosa, L. E., Dibley, M. G., Stroud, D. A., & Ryan, M. T. (2018). Building a complex complex: Assembly of mitochondrial respiratory chain complex I. Semin Cell Dev Biol , 76 , 154-162. https://doi.org/10.1016/j.semcdb.2017.08.011
Gudmundsson, S., Singer-Berk, M., Watts, N. A., Phu, W., Goodrich, J. K., Solomonson, M., . . . O’Donnell-Luria, A. (2021). Variant interpretation using population databases: Lessons from gnomAD.Hum Mutat . https://doi.org/10.1002/humu.24309
Heide, H., Bleier, L., Steger, M., Ackermann, J., Dröse, S., Schwamb, B., . . . Brandt, U. (2012). Complexome profiling identifies TMEM126B as a component of the mitochondrial complex I assembly complex. Cell Metab , 16 (4), 538-549. https://doi.org/10.1016/j.cmet.2012.08.009
Hirst, J. (2013). Mitochondrial complex I. Annu Rev Biochem ,82 , 551-575. https://doi.org/10.1146/annurev-biochem-070511-103700
Kobayashi, Y., Yang, S., Nykamp, K., Garcia, J., Lincoln, S. E., & Topper, S. E. (2017). Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation. Genome Med , 9 (1), 13. https://doi.org/10.1186/s13073-017-0403-7
Lake, N. J., Compton, A. G., Rahman, S., & Thorburn, D. R. J. A. o. n. (2016). Leigh syndrome: one disorder, more than 75 monogenic causes.79 (2), 190-203.
Landrum, M. J., Lee, J. M., Benson, M., Brown, G. R., Chao, C., Chitipiralla, S., . . . Maglott, D. R. (2018). ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res , 46 (D1), D1062-d1067. https://doi.org/10.1093/nar/gkx1153
Lex, A., Gehlenborg, N., Strobelt, H., Vuillemot, R., & Pfister, H. (2014). UpSet: Visualization of Intersecting Sets. IEEE Trans Vis Comput Graph , 20 (12), 1983-1992. https://doi.org/10.1109/tvcg.2014.2346248
Lou, X., Shi, H., Wen, S., Li, Y., Wei, X., Xie, J., . . . Lyu, J. (2018). A Novel NDUFS3 mutation in a Chinese patient with severe Leigh syndrome. J Hum Genet , 63 (12), 1269-1272. https://doi.org/10.1038/s10038-018-0505-0
Mimaki, M., Wang, X., McKenzie, M., Thorburn, D. R., & Ryan, M. T. (2012). Understanding mitochondrial complex I assembly in health and disease. Biochim Biophys Acta , 1817 (6), 851-862. https://doi.org/10.1016/j.bbabio.2011.08.010
Rahman, S., Blok, R. B., Dahl, H. H., Danks, D. M., Kirby, D. M., Chow, C. W., . . . Thorburn, D. R. (1996). Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol , 39 (3), 343-351. https://doi.org/10.1002/ana.410390311
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., . . . Rehm, H. L. (2015). Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med , 17 (5), 405-424. https://doi.org/10.1038/gim.2015.30
Sánchez-Caballero, L., Ruzzenente, B., Bianchi, L., Assouline, Z., Barcia, G., Metodiev, M. D., . . . Rötig, A. (2016). Mutations in Complex I Assembly Factor TMEM126B Result in Muscle Weakness and Isolated Complex I Deficiency. Am J Hum Genet , 99 (1), 208-216. https://doi.org/10.1016/j.ajhg.2016.05.022
Schapira, A. H. (1993). Mitochondrial complex I deficiency in Parkinson’s disease. Adv Neurol , 60 , 288-291.
Schiff, M., Haberberger, B., Xia, C., Mohsen, A. W., Goetzman, E. S., Wang, Y., . . . Vockley, J. (2015). Complex I assembly function and fatty acid oxidation enzyme activity of ACAD9 both contribute to disease severity in ACAD9 deficiency. Hum Mol Genet , 24 (11), 3238-3247. https://doi.org/10.1093/hmg/ddv074
Schubert Baldo, M., & Vilarinho, L. (2020). Molecular basis of Leigh syndrome: a current look. Orphanet J Rare Dis , 15 (1), 31. https://doi.org/10.1186/s13023-020-1297-9
Sherry, S. T., Ward, M. H., Kholodov, M., Baker, J., Phan, L., Smigielski, E. M., & Sirotkin, K. (2001). dbSNP: the NCBI database of genetic variation. Nucleic Acids Res , 29 (1), 308-311. https://doi.org/10.1093/nar/29.1.308
Stenson, P. D., Mort, M., Ball, E. V., Shaw, K., Phillips, A., & Cooper, D. N. (2014). The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet ,133 (1), 1-9. https://doi.org/10.1007/s00439-013-1358-4
Theunissen, T. E. J., Gerards, M., Hellebrekers, D., van Tienen, F. H., Kamps, R., Sallevelt, S., . . . Smeets, H. J. M. (2017). Selection and Characterization of Palmitic Acid Responsive Patients with an OXPHOS Complex I Defect. Front Mol Neurosci , 10 , 336. https://doi.org/10.3389/fnmol.2017.00336
Tinker, R. J., Lim, A. Z., Stefanetti, R. J., & McFarland, R. (2021). Current and Emerging Clinical Treatment in Mitochondrial Disease.Mol Diagn Ther , 25 (2), 181-206. https://doi.org/10.1007/s40291-020-00510-6
Volodarsky, M., Zilberman, U., & Birk, O. S. (2015). Novel FAM20A mutation causes autosomal recessive amelogenesis imperfecta. Arch Oral Biol , 60 (6), 919-922. https://doi.org/10.1016/j.archoralbio.2015.02.018
Wang, M., & Marín, A. (2006). Characterization and prediction of alternative splice sites. Gene , 366 (2), 219-227. https://doi.org/10.1016/j.gene.2005.07.015
Wei, X., Du, M., Li, D., Wen, S., Xie, J., Li, Y., . . . Fang, H. (2020). Mutations in FASTKD2 are associated with mitochondrial disease with multi-OXPHOS deficiency. Hum Mutat , 41 (5), 961-972. https://doi.org/10.1002/humu.23985
Wiel, L., Baakman, C., Gilissen, D., Veltman, J. A., Vriend, G., & Gilissen, C. (2019). MetaDome: Pathogenicity analysis of genetic variants through aggregation of homologous human protein domains.Hum Mutat , 40 (8), 1030-1038. https://doi.org/10.1002/humu.23798
Zheng-Bradley, X., & Flicek, P. (2017). Applications of the 1000 Genomes Project resources. Brief Funct Genomics , 16 (3), 163-170. https://doi.org/10.1093/bfgp/elw027